Clinical Trial Update: Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oxaliplatin in young patients with recurrent solid tumors that have not responded to prior treatment has completed. The study included …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brainstem Glioma
• Ewing Sarcoma
• Germ Cell Tumor
• Hepatoblastoma
• Neuroblastoma
• Osteosarcoma
• Rhabdomyosarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Eloxatin (oxaliplatin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Childhood Central Nervous System Germ Cell Tumor, Childhood Extragonadal Germ Cell Tumor | Phase 2 | Status: COMPLETED